Articles database
 
 
Web AnyArticles.com
Browse by Category:
  Self Improvement >
  Subcategories
Attraction Attraction (882)
Coaching Coaching (656)
Creativity Creativity (300)
Goal Setting Goal Setting (692)
Grief Loss Grief Loss (162)
Happiness Happiness (425)
Innovation Innovation (143)
Inspirational Inspirational (1130)
Leadership Leadership (409)
Motivation Motivation (1061)
Organizing Organizing (287)
Positive Attitude Positive Attitude (842)
Spirituality Spirituality (1474)
Stress Management Stress Management (751)
Success Success (1215)
Time Management Time Management (405)


  Categories :
 
  Arts and Entertainment
  Automotive
  Business
  Communications
  Computers and Technology
  Finance
  Food and Drink
  Health and Fitness
  Home and Family
  Home Based Business
  Internet and Businesses Online
  Kids and Teens
  Legal
  News and Society
  Recreation and Sports
  Reference and Education
  Self Improvement
  Shopping and Product Reviews
  Travel and Leisure
  Womens Interests
  Writing and Speaking
  Random Category
  Funny stuff
  Women Issues
  Communications
Happiness article : Vagus Nerve Stimulation is FDA Approved for Depression and being prescribed by MDs
 

Self Improvement > Happiness > Vagus Nerve Stimulation is FDA Approved for Depression and being prescribed by MDs

0 Reviews [ add review ], Article rating : 0.00, 0 votes. Author : Charles Donovan

Vagus nerve stimulation(VNS) is a safe, FDA approved treatment for chronic or recurrent depression. VNS has increasingly been more accepted by the psychiatric community as its robust antidepressants effects of this treatment has on key areas of the brain is better understood by psychiatrists.

During 2006, the manufacturer of the stimulator plans to continue to educate psychiatrists and general practioners about this ninety minute out-patient procedure. Here a few of the plans:

  • Three-hundred thirty representatives and case managers are participating in this nationwide education process. In addition to the face-to-face meetings with psychiatrists, the awareness and education process will include:

  • Satellite Broadcast Event in 50 cities for 1,750 psychiatrists
  • Fifty nationwide symposiums for 3,200 psychiatrists
  • One-hundred Regional Symposiums for 2,000 psychiatrists Ninety teleconferences
  • Continuing Medical Education Monograph (CME Credit)-7,000 psychiatrists Psychiatric Society Meetings
the efficacy and safety of vagus nerve stimulation for depresssion was published in the prestigious peer reviewed journal of Biological Psychiatry.

The data from the pivotal clinical trial of vagus nerve stimulation and depression was been on published September 1st, in the prestigious peer-reviewed journal of Biological Psychiatry. There were three articles published in Biological Psychiatry about VNS Therapy and depression. The articles confirm the association of VNS Therapy with significant antidepressant benefits that are sustained and/or growing over one year for patients with chronic or recurrent treatment-resistant depression. Secondly, the long-term safety of the procedure was confirmed.

"The response and remission and sustained long-term benefits realized by the patients treated with adjunctive VNS Therapy is remarkable, given that participants in the trials were some of the most treatment-resistant, depressed patients ever studied, with at least half having been hospitalized for the disease at least once," commented Dr. A. John Rush, MD, Professor and Vice Chairman for Research, Department of Psychiatry, Betty Jo Hay Chair in Mental Health, Rosewood Corporation Chair in Biomedical Science, University of Texas Southwestern Medical Center, Dallas, TX. "The VNS studies presented in these publications provide substantial evidence of a growing benefit of VNS Therapy over time when other treatments have not worked or have stopped working. This is particularly encouraging given the nature of treatment-resistant depression, a devastating and difficult to treat condition."

The publication of these articles is very important to you because third party payers (private insurance companies, Medicare, etc.) will help facilitate the approval of reimbursement of VNS Therapy for depression. Although reimbursement decisions will continue to be on a case-by-case basis, this is a critical next step which will be viewed very positively by insurance companies, Medicare as well as your psychiatrist.

You can learn more about this remarkable treatment at http://www.VagusNerveStimulator.com There is a free newsletter to keep you up-to-date on the latest developments on this first ever FDA approved long term treatment option for chronic or recurrent depression.

Charles Donovan was a study study subject in the FDA investigational trial of vagus nerve stimulation and chronic depression. He is the author of:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression and founder of the VagusNerveStimulator.com Web site.

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression is available on Amazon.com, Barnes & Noble.com and at http://www.vagusnervestimulator.com/book/

The book was exhibited last month at the U.S. Psychiatric and Mental Health Congress in Las Vegas, which was attended by more than 5,000 psychiatrists.


0 Reviews [ add review ], Article rating : 0.00, 0 votes. Author : Charles Donovan
Rate this story : and read/post review(s)


Article reviews



Post your review
[ Note : no HTML/URLs - will removed automatically ]
Your name
Your comments


More articles from Self Improvement > Happiness

Add article | Manage Articles | Top Rated articles | Most Reviewed articles | Contact us | Links